Tue, December 19, 2023

Derek Archila Maintained (VTYX) at Hold with Decreased Target to $3 on, Dec 19th, 2023

Derek Archila of Wells Fargo, Maintained "Ventyx Biosciences, Inc." (VTYX) at Hold with Decreased Target from $8 to $3 on, Dec 19th, 2023.

Derek has made no other calls on VTYX in the last 4 months.



There are 5 other peers that have a rating on VTYX. Out of the 5 peers that are also analyzing VTYX, 4 agree with Derek's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Alex Thompson of "Stifel" Maintained at Hold with Decreased Target to $2 on, Monday, December 18th, 2023
  • Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold and Decreased Target to $5 on, Friday, November 10th, 2023
  • Emily Bodnar of "HC Wainwright & Co." Downgraded from Strong Buy to Hold on, Tuesday, November 7th, 2023
  • Vikram Purohit of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $6 on, Tuesday, November 7th, 2023


This is the rating of the analyst that currently disagrees with Derek


  • Simon Flannery of "Morgan Stanley" Maintained at Buy with Increased Target to $46 on, Tuesday, August 29th, 2023